A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 3,866 shares of RDY stock, worth $57,990. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,866
Previous 5,479 29.44%
Holding current value
$57,990
Previous $417,000 26.38%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$75.41 - $84.21 $121,636 - $135,830
-1,613 Reduced 29.44%
3,866 $307,000
Q2 2024

Jul 30, 2024

BUY
$68.26 - $76.19 $373,996 - $417,445
5,479 New
5,479 $417,000
Q1 2023

May 04, 2023

BUY
$51.63 - $56.93 $541,288 - $596,854
10,484 New
10,484 $596,000
Q4 2021

Feb 08, 2022

SELL
$59.5 - $67.25 $327,547 - $370,211
-5,505 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$60.19 - $75.29 $46,707 - $58,425
776 Added 16.41%
5,505 $359,000
Q2 2021

Aug 11, 2021

BUY
$62.12 - $74.2 $60,691 - $72,493
977 Added 26.04%
4,729 $348,000
Q1 2021

May 13, 2021

SELL
$57.98 - $73.08 $213,598 - $269,226
-3,684 Reduced 49.54%
3,752 $230,000
Q4 2020

Feb 10, 2021

BUY
$62.61 - $71.29 $22,163 - $25,236
354 Added 5.0%
7,436 $530,000
Q3 2020

Nov 12, 2020

BUY
$51.39 - $72.41 $54,524 - $76,827
1,061 Added 17.62%
7,082 $493,000
Q2 2020

Aug 11, 2020

SELL
$39.55 - $54.65 $35,476 - $49,021
-897 Reduced 12.97%
6,021 $319,000
Q1 2020

May 12, 2020

SELL
$34.75 - $45.85 $41,839 - $55,203
-1,204 Reduced 14.82%
6,918 $279,000
Q4 2019

Feb 12, 2020

SELL
$36.66 - $41.78 $6,012 - $6,851
-164 Reduced 1.98%
8,122 $330,000
Q3 2019

Nov 12, 2019

SELL
$34.82 - $39.26 $6,720 - $7,577
-193 Reduced 2.28%
8,286 $314,000
Q2 2019

Aug 13, 2019

BUY
$36.05 - $42.76 $305,667 - $362,562
8,479 New
8,479 $318,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.49B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.